Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age
NCT05590884
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Central Nervous System Diseases
Pediatric Disorder
Body Indication
Interventions
DRUG:
Gadopiclenol
Sponsor
Guerbet